<?xml version="1.0" encoding="UTF-8"?>
<p id="par0095">Currently available antiviral drugs were mainly designed to target a specific viral or human protein crucial for infection with a specific type of virus [
 <xref rid="bib0005" ref-type="bibr">1</xref>]. Considering the diversity and constant mutations of viruses, it will not come as a surprise if these antiviral drugs are shown to be inefficient against the new SARS-CoV-2 virus and thus not adequate for repurposing.
</p>
